1. Home /
  2. Life Sciences

Life Sciences

A Fresh Look at Medical Device Maker DexCom After Earnings

The shares gapped higher Friday to refresh the uptrend.

Struggling 3M Needs to Form a Base, but Lowered Guidance Won't Help

The diversified technology giant has been bearish for months and is likely to remain so after reducing its full-year revenue and profit forecasts.

Bearish Bets: 3 Stocks You Should Think About Shorting This Week

These recently downgraded names are displaying both quantitative and technical deterioration.

Harmony Biosciences Could Soon Sing an Uplifting Tune

Here's our trading strategy for the shares.

My Chart Intel Says to Shy Away From Intellia Therapeutics

The technical signals of the genome editing company are largely bearish and indicate its stock is poised to weaken.

We're Changing Our DexCom Strategy as the Shares Move Higher

Here's what traders should do now.

Edwards Lifesciences Sends Positive Signals but Merits Wait-and-See Approach

The charts of the producer of medical technology show promise but could be derailed by weakness in the broader markets.

I've Got a Rough Floorplan for How to Play Blueprint Medicines

The charts for this drug developer are starting to take shape.

Edwards Lifesciences Offers Promise for Patients and Investors

Traders have been shifting from aggressive selling to aggressive buying.

This Won't Hurt a Bit: Moderna Could Rally 25% From Here

The stock is ready to make a recovery rally.